期刊文献+

α-吡咯烷酮乙酰胺的HPLC测定 被引量:1

Determination of α-oxo-1-pyrrolidineacetamide by HPLC
下载PDF
导出
摘要 建立了测定样品中α吡咯烷酮乙酰胺含量的高效液相色谱法。采用的色谱柱为十八烷基硅烷键合相,硅胶为填充剂(25cm×4.6mm,粒径5μm,);流动相为甲醇乙腈水(体积比5∶2∶3);流速1mL/min;紫外检测波长230nm;内标为对乙酰氨基酚;进样量20μL;线性范围0.1~0.5mg/mL;相关系数为0.9998;回收率99.8%;相对标准偏差0.33%.与氮测定法比较,本法操作简便,结果准确。 A HPLC method for the determination of the content of 2-oxo-l-pyrrolidineacetamide in product was established, A C18 (25 cm × 4. 6 mm, 5 μm) column was used as the stationary phase, filled by silica gel; the mobile phase was composed of methanol-acetonitrile-water (5 : 2 : 3) ; at a flow rate of 1.0 mL/min and UV detection wavelength at 230 nm; paracetamol was used as internal standard; the correlation coefficient of the calibration curve was 0. 999 8 in the range of 0.1-0.5 mg/mL; the average rate of recovery was 99.8 % RSD=0. 33%. Comparing with nitrogen mensuration, the method is simple, quick and accurate.
出处 《太原理工大学学报》 CAS 北大核心 2005年第4期480-482,485,共4页 Journal of Taiyuan University of Technology
关键词 高效液相色谱法 样品 α-吡咯烷酮乙酰胺 测定 HPLC sample 2-oxo-l-pyrrolidineacetamide determination
  • 相关文献

参考文献8

  • 1熊发高,汪若跃.吡拉西坦含量的HPLC测定[J].中国医药工业杂志,2000,31(9):410-411. 被引量:4
  • 2于世林.高效液相色谱方法及应用[M].北京:化学工业出版社,1999.3.
  • 3药检委员会.卫生部药品标准(第二部)[S](第三册)[M].北京:人民卫生出版社,1994.28.
  • 4孔令星,王正容,李玉珍.高效液相色谱法测定脑复康注射液的含量[J].中国药事,2002,16(1):40-41. 被引量:3
  • 5Mascher H, Kikuta C. Rapid method for the sensitive determination of piracetam in plasma by high performance liquid chromatoraphy[J]. J Pharm Biomed Anal, 1989, 7: 913-916.
  • 6Louchahi K, Tod M , Bommardel P, et al. Determination of piracetam in human plasma and urine by liquid chromatography[J]. J Chromatogrhy B Biomed Appl, 1995, 663: 385-389.
  • 7药检委员会.卫生部药品标准新药转正标准[S](第十二册)[M].北京:人民卫生出版社,1997.89.
  • 8梁奕昌,朱广一,马晓国.α-吡咯烷酮乙酸甲酯的HPLC测定[J].分析测试学报,1999,18(4):61-63. 被引量:3

二级参考文献9

共引文献12

同被引文献10

  • 1吴芳丽,李爱珍,毛慧芳.RP-HPLC测定石蒜中加兰他敏含量[J].中国中药杂志,2005,30(7):523-525. 被引量:22
  • 2Scott L J,Goa K L.Galanthamine:a review of its use in Alzheimer's disease[J].Drugs,2000,60 (5):1095-1100.
  • 3Bickel U,Thomsen T,Weber W,et al.Pharmaeo kinetics of galanthamine in humans and corresponding cholinesterase inhibition[J].Clin Pharmacol Ther,1991,50(4):420-423.
  • 4Bachus R,Bickel U,Thomsen T,et al.The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6[J].Pharmacogenetics,1999,9(6):661.
  • 5Dimitrov T C,Paskov V D.Effect of the combined application of nivalin and vitamines of the group on the functional state of the centralnervous system(CNS)[J].Comples Redus de Im Academie B ulgare de Sciences,1998,41(9):143-145.
  • 6中华人们共和国药典委员会编.中华人民共和国药典(2005 二部)[M].北京:化学工业出版社,2005:410.
  • 7Dal-Bianco P,Maly J,Wober C h,et al.Galanthamine treatment in Alzheimer's disease[J].J Neural Transm Suppl,1991,33:59-62.
  • 8梁奕昌,朱广一,马晓国.α-吡咯烷酮乙酸甲酯的HPLC测定[J].分析测试学报,1999,18(4):61-63. 被引量:3
  • 9钱南萍.HPLC法测定氢溴酸加兰他敏分散片的含量[J].中国药师,2003,6(7):430-431. 被引量:9
  • 10李翼,戚燕,吴松.RP-HPLC法测定氢溴酸加兰他敏口服液含量及有关物质[J].药物分析杂志,2003,23(5):365-367. 被引量:6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部